Nicolas Chatain

Hypoxia-inducible factor 1 (HIF-1) is a new therapeutic target in JAK2V617F-positive myeloproliferative neoplasms

Julian Baumeister, Nicolas Chatain, Annika Hubrich et al. · Leukemia · 2019 · 114 citations

Hematological Malignancy, New Therapeutic Target, Hypoxia (Medicine) +8

Calreticulin-mutant proteins induce megakaryocytic signaling to transform hematopoietic cells and undergo accelerated degradation and Golgi-mediated secretion

Lijuan Han, Claudia Schubert, Johanna Köhler et al. · Journal of Hematology & Oncology · 2016 · 98 citations · Full text

Tyrosine kinase inhibitor–induced defects in DNA repair sensitize FLT3(ITD)-positive leukemia cells to PARP1 inhibitors

Silvia Maifrede, Margaret Nieborowska-Skorska, Katherine Sullivan-Reed et al. · Blood · 2018 · 73 citations · Full text

JAK2V617F but not CALR mutations confer increased molecular responses to interferon-α via JAK1/STAT1 activation

Julia Czech, Sabrina Cordua, Barbora Weinbergerová et al. · Leukemia · 2018 · 57 citations

Transcriptional Regulation, Increased Molecular Responses, Signal Transduction +13

Intercellular trafficking of the nuclear oncoprotein DEK

Anjan K. Saha, Ferdinand Kappes, Amruta Mundade et al. · Proceedings of the National Academy of Sciences · 2013 · 51 citations · Full text

Molecular Biology, Cell Cycle, Dek Internalization +17